Abstract
A panel of members of the American Association of Ophthalmic Oncologists and Pathologists (AAOOP) with support from the American Association for Pediatric Ophthalmology and Strabismus and the American Academy of Pediatrics (AAP) was convened. Consensus statement from the panel recommended dedicated ophthalmic screening for all children at risk for retinoblastoma above the population risk. Risk stratification including genetic testing and counseling serves as the basis for screening of children at elevated risk for development of retinoblastoma. Frequency of examinations is adjusted on the basis of expected risk for RB1 mutation. Examination schedules are stratified on the basis of high-, intermediate-, and low-risk children. Children at high risk for retinoblastoma require more frequent screening, which may preferentially be examinations under anesthesia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Skalet AH, Gombos DS, Gallie BL, et al. Screening of children at risk for retinoblastoma: consensus report from the American Association of Ophthalmic Oncologists and Pathologists. Ophthalmology. 2018;125(3):453–8.
Moll AC, Kuik DJ, Bouter LM, et al. Incidence and survival of retinoblastoma in The Netherlands: a register based study 1862-1995. Br J Ophthalmol. 1997;81(7):559–62.
Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975-2004. Br J Ophthalmol. 2009;93(1):21–3.
Rothschild PR, Lévy D, Savignoni A, et al. Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study. Eye (Lond). 2011;25(12):1555–61.
Imhof SM, Moll AC, Schouten-van Meeteren AY. Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands. Br J Ophthalmol. 2006;90(7):875–8.
Gallie B. Canadian guidelines for retinoblastoma care. Can J Ophthalmol. 2009;44(6):639–42.
Al-Nawaiseh I, Ghanem AQ, Yousef YA. Familial retinoblastoma: raised awareness improves early diagnosis and outcome. J Ophthalmol. 2017;2017:5053961.
Richter S, Vandezande K, Chen N, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet. 2003;72(2):253–69.
Dhar SU, Chintagumpala M, Noll C, et al. Outcomes of integrating genetics in management of patients with retinoblastoma. Arch Ophthalmol. 2011;129(11):1428–34.
King BA, Parra C, Li Y, et al. Spatiotemporal patterns of tumor occurrence in children with intraocular retinoblastoma. PLoS One. 2015;10(7):e0132932.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gombos, D.S., Skalet, A.H. (2019). Screening Children at Risk for Retinoblastoma. In: Berry, J., Kim, J., Damato, B., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-11123-6_24
Download citation
DOI: https://doi.org/10.1007/978-3-030-11123-6_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11122-9
Online ISBN: 978-3-030-11123-6
eBook Packages: MedicineMedicine (R0)